TY - BOOK AU - Hyman,Paul AU - Abedon,Stephen T. ED - C.A.B. International, TI - Bacteriophages in health and disease T2 - Advances in molecular and cellular microbiology AV - QR342 .B3384 2012eb U1 - 579.2/6 23 PY - 2012/// CY - Wallingford, Oxfordshire, UK PB - CABI KW - Bacteriophages KW - Therapeutic use KW - Biological Therapy KW - methods KW - Biological Control KW - Pesticides and Drugs; Control, (New March 2000) KW - Host Resistance and Immunity KW - Food Contamination, Residues and Toxicology KW - Prion, Viral, Bacterial and Fungal Pathogens of Humans, (New March 2000) KW - Non-drug Therapy and Prophylaxis of Humans, (New March 2000) KW - Genetic Engineering, Gene Transfer and Transgenics, (New June 2002) KW - Diagnostic, Therapeutic and Pharmacological Biotechnology, (New June 2002) KW - Molecular Biology and Molecular Genetics, (Discontinued March 2000, Reinstated and Revised June 2002) KW - Biochemistry and Physiology of Microorganisms, (New March 2000) KW - Genetics and Molecular Biology of Microorganisms, (New March 2000) KW - Bacteria KW - cabt KW - Man KW - Antibacterial agents KW - Antibacterial properties KW - Antiobiotics KW - Bacterial diseases KW - Biotechnology KW - DNA KW - DNA vaccines KW - Enzymes KW - Food contamination KW - Food safety KW - Foods KW - Gene therapy KW - Genes KW - Human diseases KW - Immune response KW - Immune system KW - Immunomodulatory properties KW - Microbial contamination KW - Pathogenesis KW - Pathogens KW - Phage vectors KW - Safety KW - Therapy KW - Vaccine development KW - Wound infections KW - Wounds KW - Electronic books N1 - Includes bibliographical references and index; Phages / Stephen T. Abedon -- Bacteriophages as part of the human microbiome / Andrey V. Letarov -- Diseases caused by phages / Sarah Kuhl, Stephen T. Abedon, and Paul Hyman -- Prophage-induced changes in cellular cytochemistry and virulence / Gail E. Christie, Heather E. Allison, John Kuzio, W. Michael McShan, Matthew K. Waldor and Andrew M. Kropinski -- The lion and the mouse : how bacteriophages create, liberate, and decimate pathogens / Heather Hendrickson -- Phages and bacterial epidemiology / Michele L. Williams and Jeffrey T. LeJeune -- Phages as therapeutic delivery vehicles / Jason Clark, Stephen T. Abedon, and Paul Hyman -- Clinical applications of phage display peptides / Don L. Siegel -- Phages and their hosts : a web of interactions applications to drug design / Jeroen Wagemans and Rob Lavigne -- Bacteriophage-based methods of bacterial detection and identification / Christopher R. Cox -- Phage detection as indication of fecal contamination / Lawrence D. Goodridge and Travis Steiner -- Phage translocation, safety, and immunomodulation / Natasza Olszowska-Zaremba, Jan Borysowski, Krystyna Da̜browska and Andrzej Górski -- Phage therapy of wounds and related purulent infections / Catherine Loc-Carrillo, Sijia Wu, and James Peter Beck -- Phage therapy of non-wound infections / Ben Burrowes and David R. Harper -- Phage-based enzybiotics / Yang Shen, Michael S. Mitchell, David M. Donovan and Daniel C. Nelson -- Role of phages in control of bacterial pathogens in food / Yan D. Niu, Kim Stanford, Tim A. McAllister and Todd R. Callaway -- Phage-therapy best practices / Stephen T. Abedon; Access limited to subscribing institution; Also available in print format N2 - This book, Bacteriophages in Health and Disease, is an effort to provide an introduction to the breadth of roles that phages play or can play in our everyday lives. To capture this variety of phage roles in human conditions, both natural and applied, the book is divided into three parts. A brief introduction to various concepts and terminology associated with phages is provided in chapter 1. Part I (chapters 2-6) considers the role of phages in the natural state. That is, where phages are, how they contribute directly to disease, the underlying mechanism by which phages do this, and how they can contribute indirectly to disease, that is, to pathogen evolution. Part II (chapters 7-11) considers various phage-based technologies other than the use of whole phages to combat bacterial infections (i.e. besides phage therapy). This includes in particular the use of both modified and 'disembodied' phage parts. Phages thus can serve as carriers and delivery vehicles of DNA and also of other chemicals, including serving as vectors for either gene therapy or DNA vaccines. Part III (chapters 12-17) covers phage-based antibacterial strategies. It includes chapters on: phage translocation, safety and immunomodulation; phage therapy of wounds and related purulent infections; phage therapy of non-wound infections; phage-based enzybiotics; and phage-based control of bacterial pathogens in food. The final chapter of this book is targeted to would-be phage therapy experimentalists, one that considers, in light of phage properties, how phage therapy protocols may be developed in terms of the use of animal models of bacterial disease UR - https://dx.doi.org/10.1079/9781845939847.0000 ER -